Figure 7. Molecular subtypes analysis and immune microenvironment landscape characterization. (A) Identification of the molecular subtypes for ccRCC. (B) Clinical prognostic analysis of Cluster A, Cluster B and Cluster C. (C) PCA score plot shows a significant distribution pattern of patients in Cluster A, Cluster B and Cluster C. (D–F) Tumor purity, immune and ESTIMATE scores. The proportion of immune cells calculated by (G) CIBERSORT and (H) ssGSEA.